I agree that this site is using cookies. You can find further informations here.
X
Loretta J. Nastoupil
312  results:
Search for persons X
?
1

Outcomes in Patients (pts) with R/R Large B-Cell Lymphoma (..:

Caimi, Paolo ; Schuster, Stephen J. ; Nastoupil, Loretta J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S188-S189 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Indirect Treatment Comparisons of Mosunetuzumab With Third-..:

Bosch, Francesc ; Kuruvilla, John ; Vassilakopoulos, Theodoros P....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. 105-121 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Multicenter, Real-World Study in Patients with R/R Large B-..:

Palomba, M. Lia ; Crombie, Jennifer L. ; Nastoupil, Loretta J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S40-S41 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Response-adapted ultra-low-dose 4 Gy radiation as definitiv..:

Gunther, Jillian R ; Xu, Jie ; Bhutani, Manoop S...
The Lancet Haematology.  11 (2024)  7 - p. e521-e529 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Safety, efficacy and determinants of response of allogeneic..:

Marin, David ; Li, Ye ; Basar, Rafet...
Nature Medicine.  30 (2024)  3 - p. 772-784 , 2024
Link: https://doi.org/10.1038/..
 
?
6

Clinical Factors Associated with Failure to Manufacture Com..:

Patel, Romil D ; Feng, Lei ; Gurumurthi, Ashwath...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S214 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Safety and activity of lenalidomide in combination with obi..:

Gurumurthi, Ashwath ; Chin, Collin K. ; Feng, Lei...
eClinicalMedicine.  74 (2024)  - p. 102747 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity..:

Khurana, Arushi ; Mwangi, Raphael ; Nastoupil, Loretta J....
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
9

Analysis of Colonic FDG Uptake and Association with Respons..:

Zaki, Ajlan Al ; Feng, Lei ; Saini, Neeraj Y....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S218 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Clinical Outcomes of Patients with Relapsed/Refractory Foll..:

Schuster, Stephen J. ; Fowler, Nathan H. ; Dickinson, Michael...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S38-S39 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Impact of patient demographics and neighborhood socioeconom..:

Nze, Chijioke ; Andersen, Clark R. ; Ayers, Amy A....
Blood Advances.  8 (2024)  14 - p. 3825-3837 , 2024
Link: https://doi.org/10.1182/..
 
?
12

Optimizing the Post-CAR T Monitoring Period for Axicabtagen..:

Ahmed, Nausheen ; Wesson, William ; Lutfi, Forat...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
13

Defining the Optimal Post-CART Monitoring Period in Recipie..:

Wesson, William ; Riedell, Peter A. ; Porter, David L....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S206-S207 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances.  8 (2024)  4 - p. 1042-1050 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Severe reactivation of seronegative occult hepatitis B afte..:

Torres, Harrys A ; Mustafayev, Khalis ; Nastoupil, Loretta J.
The Lancet.  403 (2024)  10434 - p. 1372-1373 , 2024
Link: https://doi.org/10.1016/..
 
1-15